New Vaccine “Booster” Found To Promote Powerful Anti-Tumor Immunity

Researchers at Trinity College Dublin have achieved a significant breakthrough that could lead to the development of innovative immune therapies for cancer. They found that a vaccine adjuvant or “booster,” known as C100, when injected directly into tumors in an animal model, promotes potent anti-tumor immunity.

The scientists found that C100, derived from chitin – one of the most common building materials in nature, and which gives strength to the exoskeletons of crustaceans, insects, and the cell walls of fungi – is highly effective at stimulating a key sensing and signaling molecule which regulates anti-tumour immune responses.

Their highly promising work has been published today in the leading international journal Cell Reports Medicine.